NASDAQ · NXTT

Next Technology Holding Inc.

$0.61 -$0.00 (-0.62%) 1D Pre-market

Key Metrics

$46.84M
Market cap
1.26×
P/E · TTM
$12.08M
Revenue · TTM
$37.31M
Net income
EPS · TTM $76.46
Dividend yield
Free cash flow
Beta · 1Y 1.01
EBITDA · TTM
Gross margin 15.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Jan 30 high, the share price fell 88%.

    Peak close $4.92 on Jan 30; trough close $0.61 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -88%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 27
    The stock moved +48.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 27
  • Mar 25
    The stock moved +77.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 25

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$46.84M
Enterprise value
Shares outstanding76.3M
52-wk range$0.45 – $444.00
Avg volume · 20D210.0K
Net cash
Book value / share$1,046.78
IndustryServices-Computer Processing & Data Preparation
ExchangeNASDAQ
About Next Technology Holding Inc.
IPO dateApr 8, 2020
Employees28

Next Technology Holding Inc provides software development services.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E1.26
P/S3.88
P/FCF
EV/EBITDA
EV/Sales
Graham №$1,341.94

Profitability

Gross 15.2%
Operating -715.1%
Net 308.9%
FCF
ROE / ROIC 12.6% · -21.5%

Financial Health

Current ratio180.91
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$548.17M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

1.5
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$1,341.94 vs $0.61
Trades below classic defensive value — Graham-cheap
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings